Fri, July 29, 2022
Thu, July 28, 2022
Wed, July 27, 2022

Ryan MacDonald Downgraded (TDOC) to Hold on, Jul 28th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ld-downgraded-tdoc-to-hold-on-jul-28th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Ryan MacDonald of Needham, Downgraded "Teladoc Health, Inc." (TDOC) to Hold on, Jul 28th, 2022.

Ryan has made no other calls on TDOC in the last 4 months.



There are 11 other peers that have a rating on TDOC. Out of the 11 peers that are also analyzing TDOC, 9 agree with Ryan's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Grossman of "Stifel" Maintained at Hold with Decreased Target to $36 on, Wednesday, June 29th, 2022
  • John Eade of "Argus Research" Downgraded from Strong Buy to Hold on, Thursday, May 5th, 2022
  • Jonathan Yong of "Credit Suisse" Downgraded from Buy to Hold and Decreased Target to $35 on, Thursday, April 28th, 2022
  • Matt Hewitt of "Craig-Hallum" Maintained at Hold with Decreased Target to $30 on, Thursday, April 28th, 2022
  • Ryan Daniels of "William Blair" Downgraded from Buy to Hold on, Thursday, April 28th, 2022
  • Sandy Draper of "Guggenheim" Downgraded from Strong Buy to Hold on, Thursday, April 28th, 2022
  • Stan Berenshteyn of "Wells Fargo" Downgraded from Buy to Hold and Held Target at $40 on, Thursday, April 28th, 2022
  • George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $44 on, Thursday, April 28th, 2022
  • Daniel Grosslight of "Citigroup" Downgraded from Strong Buy to Hold and Decreased Target to $43 on, Thursday, April 28th, 2022


These are the ratings of the 2 analyists that currently disagree with Ryan


  • Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $50 on, Thursday, April 28th, 2022
  • Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $65 on, Thursday, April 28th, 2022

Publication Contributing Sources